This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Banyan Biomarkers, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Michael Catania: Innovator in Neurological Diagnostics
Introduction
Michael Catania is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of neurological diagnostics through his innovative work. With a total of 2 patents, Catania's inventions focus on the detection of brain injuries and related conditions.
Latest Patents
Catania's latest patents include antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP). These inventions provide anti-UCH-L1 antibodies and anti-GFAP antibodies for in vitro detection of UCH-L1 and GFAP in samples from individuals suspected of having brain injuries. The methods, systems, and kits developed for diagnosing neurological damage, such as mild traumatic brain injury, are crucial for advancing medical diagnostics.
Career Highlights
Michael Catania is currently associated with Banyan Biomarkers, Inc., where he continues to innovate in the field of medical diagnostics. His work has the potential to significantly impact the way brain injuries are diagnosed and treated.
Collaborations
Catania collaborates with Ronald L Hayes, further enhancing the research and development efforts at Banyan Biomarkers, Inc.
Conclusion
Michael Catania's contributions to neurological diagnostics through his patents and collaborations are paving the way for improved detection and treatment of brain injuries. His work exemplifies the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile